 |
1,2:5,6-dianhydrogalactitol |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2016-04-19 00:00:00 |
| Sponsor | DelMar Pharmaceuticals, Inc. (Clinical Operations);3475 Edison Way, Suite R;Menlo Park, California, 94025 |
